Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemia.
Bluteau D, Gilles L, Hilpert M, Antony-Debré I, James C, Debili N, Camara-Clayette V, Wagner-Ballon O, Cordette-Lagarde V, Robert T, Ripoche H, Gonin P, Swierczek S, Prchal J, Vainchenker W, Favier R, Raslova H. Bluteau D, et al. Blood. 2011 Dec 8;118(24):6310-20. doi: 10.1182/blood-2010-12-325555. Epub 2011 Jul 1. Blood. 2011. PMID: 21725049 Free article.
MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.
Antony-Debré I, Bluteau D, Itzykson R, Baccini V, Renneville A, Boehlen F, Morabito M, Droin N, Deswarte C, Chang Y, Leverger G, Solary E, Vainchenker W, Favier R, Raslova H. Antony-Debré I, et al. Blood. 2012 Sep 27;120(13):2719-22. doi: 10.1182/blood-2012-04-422352. Epub 2012 Jun 7. Blood. 2012. PMID: 22677128 Free article.
Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia.
Guy J, Antony-Debré I, Benayoun E, Arnoux I, Fossat C, Le Garff-Tavernier M, Raimbault A, Imbert M, Maynadié M, Lacombe F, Béné MC, Wagner-Ballon O; GEIL (Groupe d'Etude Immunologique des Leucémies). Guy J, et al. Br J Haematol. 2013 May;161(4):551-5. doi: 10.1111/bjh.12277. Epub 2013 Feb 25. Br J Haematol. 2013. PMID: 23432206 Free article.
CDK6, a new target in MLL-driven leukemia.
Antony-Debré I, Steidl U. Antony-Debré I, et al. Blood. 2014 Jul 3;124(1):5-6. doi: 10.1182/blood-2014-05-572917. Blood. 2014. PMID: 24993876 Free article.
Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.
Antony-Debré I, Manchev VT, Balayn N, Bluteau D, Tomowiak C, Legrand C, Langlois T, Bawa O, Tosca L, Tachdjian G, Leheup B, Debili N, Plo I, Mills JA, French DL, Weiss MJ, Solary E, Favier R, Vainchenker W, Raslova H. Antony-Debré I, et al. Blood. 2015 Feb 5;125(6):930-40. doi: 10.1182/blood-2014-06-585513. Epub 2014 Dec 9. Blood. 2015. PMID: 25490895 Free PMC article.
Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia.
Antony-Debré I, Duployez N, Bucci M, Geffroy S, Micol JB, Renneville A, Boissel N, Dhédin N, Réa D, Nelken B, Berthon C, Leblanc T, Mozziconacci MJ, Favier R, Heller PG, Abdel-Wahab O, Raslova H, Latger-Cannard V, Preudhomme C. Antony-Debré I, et al. Leukemia. 2016 Apr;30(4):999-1002. doi: 10.1038/leu.2015.236. Epub 2015 Aug 28. Leukemia. 2016. PMID: 26316320 No abstract available.
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.
Manchev VT, Bouzid H, Antony-Debré I, Leite B, Meurice G, Droin N, Prebet T, Costello RT, Vainchenker W, Plo I, Diop M, Macintyre E, Asnafi V, Favier R, Baccini V, Raslova H. Manchev VT, et al. J Cell Mol Med. 2017 Jun;21(6):1237-1242. doi: 10.1111/jcmm.13051. Epub 2016 Dec 20. J Cell Mol Med. 2017. PMID: 27997762 Free PMC article.
Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.
Bellanné-Chantelot C, Schmaltz-Panneau B, Marty C, Fenneteau O, Callebaut I, Clauin S, Docet A, Damaj GL, Leblanc T, Pellier I, Stoven C, Souquere S, Antony-Debré I, Beaupain B, Aladjidi N, Barlogis V, Bauduer F, Bensaid P, Boespflug-Tanguy O, Berger C, Bertrand Y, Carausu L, Fieschi C, Galambrun C, Schmidt A, Journel H, Mazingue F, Nelken B, Quah TC, Oksenhendler E, Ouachée M, Pasquet M, Saada V, Suarez F, Pierron G, Vainchenker W, Plo I, Donadieu J. Bellanné-Chantelot C, et al. Blood. 2018 Sep 20;132(12):1318-1331. doi: 10.1182/blood-2017-12-820308. Epub 2018 Jun 18. Blood. 2018. PMID: 29914977 Free PMC article.
Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML.
Duployez N, Martin JE, Khalife-Hachem S, Benkhelil R, Saada V, Marzac C, Auger N, Marceau-Renaut A, Favier R, Ballerini P, Caron O, Baruchel A, de Botton S, Preudhomme C, Micol JB, Raslova H, Antony-Debré I. Duployez N, et al. Hemasphere. 2019 Jun 4;3(3):e203. doi: 10.1097/HS9.0000000000000203. eCollection 2019 Jun. Hemasphere. 2019. PMID: 31723833 Free PMC article. No abstract available.
Dual role of EZH2 in megakaryocyte differentiation.
Mazzi S, Dessen P, Vieira M, Dufour V, Cambot M, El Khoury M, Antony-Debré I, Arkoun B, Basso-Valentina F, BenAbdoulahab S, Edmond V, Rameau P, Petermann R, Wittner M, Cassinat B, Plo I, Debili N, Raslova H, Vainchenker W. Mazzi S, et al. Among authors: antony debre i. Blood. 2021 Oct 28;138(17):1603-1614. doi: 10.1182/blood.2019004638. Blood. 2021. PMID: 34115825 Free PMC article.
25 results